Suppr超能文献

长链非编码RNA MTX2-6通过作为miR-574-5p的竞争性内源RNA在食管鳞状细胞癌中积累SMAD4来抑制细胞增殖。

LncRNA MTX2-6 Suppresses Cell Proliferation by Acting as ceRNA of miR-574-5p to Accumulate SMAD4 in Esophageal Squamous Cell Carcinoma.

作者信息

Li Jie, Han Xu, Gu Yan, Wu Jixiang, Song Jianxiang, Shi Zhan, Chang Huiwen, Liu Ming, Zhang Yajun

机构信息

The First School of Clinical Medicine, Nanjing Medical University, Nanjing, China.

Department of Cardiothoracic Surgery, Yancheng Third People's Hospital, The Sixth Affiliated Hospital of Nantong University, Yancheng, China.

出版信息

Front Cell Dev Biol. 2021 Mar 23;9:654746. doi: 10.3389/fcell.2021.654746. eCollection 2021.

Abstract

Esophageal squamous cell carcinoma (ESCC) has been one of the key causes of cancer deaths worldwide. It has been found that long non-coding RNA (lncRNA) is related to the generation and progression of various cancers (including ESCC). However, there are still many lncRNAs related to ESCC whose functions and molecular mechanisms have not been clearly elucidated. In this study, we first reported that lncRNA MTX2-6 was significantly downregulated in ESCC tissues and cell lines. The decreased expression of MTX2-6 is closely related to larger tumor and worse prognosis of ESCC patients. Through a series of functional experiments, we detected that overexpressed MTX2-6 inhibited cell proliferation and promoted cell apoptosis of ESCC and . Further studies showed that MTX2-6 exerts as a competing endogenous RNA (ceRNA) by binding miR-574-5p and elevates the expression of SMAD4 in ESCC. In summary, our results clarify the tumor suppressor roles of MTX2-6/miR-574-5p/SMAD4 axis in the progression of ESCC and provide emerging therapeutic targets for ESCC patients.

摘要

食管鳞状细胞癌(ESCC)一直是全球癌症死亡的主要原因之一。研究发现,长链非编码RNA(lncRNA)与包括ESCC在内的多种癌症的发生和发展有关。然而,仍有许多与ESCC相关的lncRNA,其功能和分子机制尚未明确阐明。在本研究中,我们首次报道lncRNA MTX2-6在ESCC组织和细胞系中显著下调。MTX2-6表达降低与ESCC患者的肿瘤较大及预后较差密切相关。通过一系列功能实验,我们检测到过表达MTX2-6可抑制ESCC细胞增殖并促进其凋亡。进一步研究表明,MTX2-6作为竞争性内源RNA(ceRNA)通过结合miR-574-5p来提高ESCC中SMAD4的表达。总之,我们的结果阐明了MTX2-6/miR-574-5p/SMAD4轴在ESCC进展中的肿瘤抑制作用,并为ESCC患者提供了新的治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fe2/8044847/b46a9402cbb5/fcell-09-654746-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验